TrialClinical pharmacology and therapeutics2019

Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study.

Femke M de Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.